We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKLZ:NYSESkillz Inc. Analysis

Data as of 2026-05-01 - not real-time

$8.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Skillz Inc. (SKLZ) is trading at $8.06, comfortably above its 20‑day ($4.51), 50‑day ($3.68) and 200‑day ($5.63) simple moving averages, and the MACD is in a bullish configuration (line above signal). The RSI of 61.6 signals momentum still on the upside but not yet overbought. Revenue surged 69% year‑over‑year to $105 M in FY 2025, driven by a 67% jump in Q4 2025, confirming the growth narrative highlighted in recent earnings calls. However, the company remains loss‑making with a gross margin of 87.5% but an operating margin of –53.9% and a trailing EPS of –$4.51, resulting in a negative PE and a steep 30‑day volatility of over 427% and a beta near 2‑3, indicating extreme price swings.
The balance sheet shows $194 M of cash offset by $129 M of debt (debt‑to‑equity >115%), and cash flow is negative, underscoring liquidity pressure. The market’s “Extreme Greed” sentiment (FGI 90.9) has driven the price toward the upper end of its 52‑week range (resistance $20), but the lack of profitability, high drawdown risk (‑75% max drawdown) and elevated sector volatility suggest caution. The stock presents a blend of high‑growth revenue potential and significant value‑style risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above key moving averages and bullish MACD
  • Elevated short‑term volatility and beta
  • Recent revenue surge but ongoing operating losses

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained revenue growth trajectory
  • High debt load and negative cash flow
  • Potential for margin improvement as platform scales

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong top‑line growth and high gross margins
  • Undervalued book value relative to price (P/B ~1.1)
  • Opportunity to capture upside if profitability and cash conversion improve

Key Metrics & Analysis

Financial Health

Revenue Growth68.90%
Profit Margin-67.38%
P/E Ratio-2.4
ROE-49.43%
ROA-13.37%
Debt/Equity115.11
P/B Ratio1.1
Op. Cash Flow$-68927000
Free Cash Flow$-39382376
Industry P/E18.9

Technical Analysis

TrendNeutral
RSI61.6
Support$2.41
Resistance$20.00
MA 20$4.51
MA 50$3.68
MA 200$5.63
MACDBullish
VolumeIncreasing
Fear & Greed Index90.89

Valuation

Target Price$2.50
Upside/Downside-68.98%
GradeFair
TypeBlend

Risk Assessment

Beta1.91
Volatility427.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.